Technical Analysis for CORT - Corcept Therapeutics Incorporated

Grade Last Price % Change Price Change
grade B 16.44 -0.48% -0.08
CORT closed down 0.48 percent on Friday, November 15, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Dec 1

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical CORT trend table...

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Calm After Storm Range Contraction -0.48%
Upper Bollinger Band Walk Strength -0.48%
Above Upper BB Strength -0.48%

Older signals for CORT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders in the United States. The company focuses on disorders that are associated with a steroid hormone called cortisol. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also involved in an on-going Phase III study of mifepristone, the active ingredient in Korlym, for treatment of the psychotic features of psychotic depression. In addition, it discovers and develops three series of novel selective GR-II antagonists. The company has research and development agreements with Argenta Discovery Limited; Sygnature Discovery Limited; ICON Clinical Research, L.P.; and MedAvante, Inc. as well as has a patent license from Stanford University for developing mifepristone. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Pharmaceutical Organ Systems Surgery Disorders Endocrine System Diabetes Mellitus Hormones Depression Cushing's Syndrome Corcept Therapeutics Hyperglycemia Cortisol Endogenous Cushing's Syndrome
Is CORT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.48
52 Week Low 9.14
Average Volume 736,297
200-Day Moving Average 12.2106
50-Day Moving Average 14.298
20-Day Moving Average 14.888
10-Day Moving Average 15.44
Average True Range 0.5545
ADX 26.19
+DI 29.1145
-DI 9.9784
Chandelier Exit (Long, 3 ATRs ) 14.9865
Chandelier Exit (Short, 3 ATRs ) 15.3435
Upper Bollinger Band 16.5956
Lower Bollinger Band 13.1804
Percent B (%b) 0.95
BandWidth 22.93928
MACD Line 0.603
MACD Signal Line 0.4072
MACD Histogram 0.1958
Fundamentals Value
Market Cap 1.86 Billion
Num Shares 113 Million
EPS 0.20
Price-to-Earnings (P/E) Ratio 82.20
Price-to-Sales 19.04
Price-to-Book 31.30
PEG Ratio 0.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.13
Resistance 3 (R3) 17.12 16.87 17.02
Resistance 2 (R2) 16.87 16.70 16.88 16.98
Resistance 1 (R1) 16.66 16.59 16.54 16.67 16.94
Pivot Point 16.41 16.41 16.35 16.42 16.41
Support 1 (S1) 16.20 16.24 16.08 16.21 15.94
Support 2 (S2) 15.95 16.13 15.96 15.90
Support 3 (S3) 15.74 15.95 15.87
Support 4 (S4) 15.75